While these medications are generally safe and may even benefit liver health, individualized assessment ensures appropriate patient selection and monitoring strategies
Ethnopharmacological study of medicinal plants in Kastamonu province (Trkiye)
REWIND expanded the evidence base by studying dulaglutide (1.5 mg/week subcutaneous) in a broader population that included a substantial proportion of primary prevention patientsonly 31% of its 9,903 participants had established cardiovascular disease at baseline [3]
Retatrutide is the most talked-about molecule in the incretin field because it does something neither semaglutide nor tirzepatide does: it engages three metabolic receptors at once
Plants use a sophisticated surveillance system to recognize signals of microbial pathogens (Jones and Dangl, 2006)
November 25 Product: Shorla Oncologys Imkeldi Indication: Several forms of leukemia and other cancers The FDA on Monday signed off on Shorla Oncologys Imkeldi, an oral solution indicated for the treatment of certain types of chronic myeloid leukemia and acute lymphoblastic leukemia, as well as other cancers such as myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis and dermatofibrosarcoma protuberans
